- Home
- PLSE vs ACHC Comparison
PLSE vs ACHC Comparison
Compare PLSE & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | ACHC |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLSE | ACHC |
|---|---|---|
| Price | $14.81 | $14.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 13 |
| Target Price | $22.00 | ★ $24.00 |
| AVG Volume (30 Days) | 198.5K | ★ 2.6M |
| Earning Date | 11-05-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.18 |
| Revenue | $86,000.00 | ★ $3,265,548,000.00 |
| Revenue This Year | N/A | $6.50 |
| Revenue Next Year | $1,002.94 | $4.38 |
| P/E Ratio | ★ N/A | $12.60 |
| Revenue Growth | N/A | ★ 4.58 |
| 52 Week Low | $12.56 | $12.63 |
| 52 Week High | $25.00 | $47.08 |
Technical Indicators
Market Signals| Indicator | PLSE | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 55.43 | 47.34 |
| Support Level | $13.17 | $13.42 |
| Resistance Level | $14.91 | $14.74 |
| Average True Range (ATR) | 0.78 | 0.53 |
| MACD | 0.05 | 0.22 |
| Stochastic Oscillator | 59.50 | 93.91 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.